Literature DB >> 3572360

Heterogeneity of the respiratory syncytial virus 22K protein revealed by Western blotting with monoclonal antibodies.

E G Routledge, M M Willcocks, L Morgan, A C Samson, R Scott, G L Toms.   

Abstract

Respiratory syncytial (RS) virus-infected HeLa, HEp-2, Vero and BS-C-1 cell lysates were electrophoresed on SDS-polyacrylamide gels under reducing conditions and analysed by Western blotting and immunoperoxidase using monoclonal antibodies specific for the 22K protein (relative mol. wt. of 23,000 in our gel system). Three novel polypeptides with mol. wt. of 24,000, 21,000 and 17,000 were stained in addition to the 23,000 polypeptide which was present in the greatest amount in all three virus strains tested regardless of host cell line. When samples were electrophoresed under non-reducing conditions each of the three higher mol. wt. polypeptides seen in reducing gels migrated as two bands (total of six bands) with altered electrophoretic mobilities. In experiments using the alkylating agent iodoacetamide under conditions where the novel 24,000, 21,000 and 17,000 polypeptides were not visible, the number of mobility variants of the 23,000 polypeptide which could be detected in non-reducing conditions was increased from two to four. At least one, and possibly three, of these variants was the result of conformational variation in the 23,000 polypeptide caused by the generation or rearrangement of intrachain disulphide bonds after the infected cells were lysed in SDS-PAGE sample buffer. Post-lysis conformational changes were minimized by treatment of the infected cells with iodoacetamide before solubilization or by decreasing the SDS concentration or using milder detergents in the lysis buffer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572360     DOI: 10.1099/0022-1317-68-4-1209

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism.

Authors:  G Ahmadian; J S Randhawa; A J Easton
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection.

Authors:  T L Cartee; G W Wertz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

Authors:  P J Openshaw; K Anderson; G W Wertz; B A Askonas
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability.

Authors:  R S Tang; N Nguyen; X Cheng; H Jin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

Authors:  P L Collins; M G Hill; J Cristina; H Grosfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.

Authors:  G A Storch; C S Park; D E Dohner
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Inactivation of respiratory syncytial virus by zinc finger reactive compounds.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.